Information icon

💚 New Oral Weight Loss Treatment Available | Use Code WL15 🌟

Weight Loss Injections

Complete our online consultation to start treatment in 4 simple & secure steps.
3 minute online consultation form
1. 3 minute online consultation form
Choose & pay for your medication
2. Choose & pay for your medication
Upload images for clinical review
3. Upload images for clinical review
Same day dispatch (order before 1pm)
4. Same day dispatch (order before 1pm)
  • UK-registered clinical team
    UK-registered clinical team
  • Confidential & secure
    Confidential & secure
  • No GP visit needed
    No GP visit needed
  • Fast & discreet delivery
    Fast & discreet delivery

Weight loss injections designed to work


Transform your weight loss journey with clinically-proven weight loss injections.

It’s hard to know where to start with your weight loss journey. That’s why our team is here to help you find the right treatment for your lifestyle.

Our injectable weight loss treatments are scientifically proven to help you lose weight when paired with an active lifestyle and balanced diet, working alongside your body and not against it.

Browse our MHRA-approved medications, trusted by 30,000+ weight loss patients with 29,000 5-star Trustpilot ratings.

Looking for weight loss tablets? Find our range of tablets and capsules here.

Compare weight loss injection options


Our range of effective weight loss injections put you in control of your weight loss journey.

Easy to administer at home, these weekly injections are designed for long-term weight loss management.

Mounjaro

Wegovy

Active ingredient

Tirzepatide - dual GIP and GLP-1 receptor agonist

Semaglutide - GLP-1 receptor agonist

How does it work?

Suppress appetite and makes you feel fuller for longer

Suppress appetite and makes you feel fuller for longer

How do I take it?

Weekly injection

Weekly injection

Dosing

6 different strengths, gradually increased every 4 weeks.

6 different strengths (up to 2.4mg), gradually increased every 4 weeks. 7.2mg available if needed.

Expected weight loss

On average 20-22.5% of starting body weight (15mg) at SURMOUNT-1 trial. (1)

On average 15-17% of starting body weight (2.4mg). On average 19-21% of mean loss at 7.2mg in STEP UP trial. (4)

Prescription required?

Yes

Yes

Additional benefits

Because of their successful weight loss journey, patients may find they experience a better quality of life, better movement and body image.

Wegovy is licensed for the reduction of the risk of major adverse cardiovascular events. Because of their successful weight loss journey, patients may find they experience a better quality of life, better movement and body image.

How do weight loss treatments work?

Because Mounjaro (Tirzepatide) and Wegovy (Semaglutide) are different active ingredients, they work slightly differently in the body — Trizepatide is a dual GIP and GLP-1 receptor agonist and Semaglutide is a singular GLP-1 agonist — however both have seen meaningful weight loss results.

Let’s look at the main ways weight loss medications work:

Appetite suppression

The active ingredients in Mounjaro and Wegovy can suppress your appetite resulting in you starting to feel less hungry. Many people report that their previous ‘food noise’ reduces significantly when using Mounjaro or Wegovy.

Feeling fuller for longer

By slowing down how long it can take food to pass through your system, the active ingredients in Mounjaro and Wegovy can help you feel fuller for longer, meaning you may feel more satisfied after eating.

It's important to remember that adopting a healthier diet and lifestyle will also play a key role in the success of your weight loss journey. Our expert team is with you at each step.

What results can you expect from weight loss injections?

The active ingredients used in Mounjaro (Tirzepatide) and Wegovy (Semaglutide) have both shown consistent weight loss results in a number of clinical trials. Here are some key results:

Mounjaro weight loss results (SURMOUNT-1 trial)

People who reached the highest Mounjaro dose (15mg) lost on average 20-22.5% of their starting body weight over 72 weeks, and:

  • 96% achieved 5% weight loss or more

  • 90% achieved 10% or more

  • 78% achieved 15% or more

  • Roughly 55% achieved 20% or more

Wegovy weight loss results (STEP UP Trial)

People who reached the highest Wegovy dose (7.2mg) lost on average 19-21% of their starting body weight over 72 weeks. Other results showed that:

  • 90.7% achieved 5% weight loss or more

  • 47.7% achieved 20% or more

  • 31.2% achieved 25% or more

Additional health benefits

Weight loss injections (Mounjaro and Wegovy injections) have been shown to offer several health advantages beyond weight loss itself.

  • Cardiovascular benefits: Clinical trials have demonstrated that Semaglutide (Wegovy) can reduce the risk of major cardiovascular events such as heart attack and stroke in people with existing heart disease (6).

  • Joint pain relief: Treatment with Semaglutide (Wegovy) demonstrated a clinically meaningful improvement in knee osteoarthritis-related pain compared to the placebo (4)

Because of their successful weight loss journey, patients on both Mounjaro and Wegovy may find they experience a better quality of life, better movement and body image.

These health benefits are typically most significant when weight loss treatment is combined with a healthy diet and regular exercise.

Am I eligible for weight loss injections?

Weight loss injections are prescription-only medications. It’s important to understand that all online weight loss consultations are clinically reviewed by independent doctors and completing a consultation doesn’t guarantee treatment.

  • Prescription weight loss treatments are typically eligible for:

  • Adults aged 18-85

  • Those with a BMI above 30 (or a BMI above 27 and a weight-related condition such as high blood pressure or cholesterol, etc.)

  • Individuals who don't have type 1 diabetes or being treated for type 2 diabetes with insulin or more than one anti-diabetic medicine.

This list is only intended as an indicator for who might be suitable for treatment. The doctors will complete a full medical review of your consultation to determine your individual suitability for treatment.

Who is not eligible for weight loss injections?

Certain conditions and medicines may make the use of weight loss injections not suitable and our prescribers will guide you as to whether it is safe to prescribe according to your medical history.

Advisory information

For menopausal women taking HRT, you should consider changing oral oestrogen to transdermal oestrogen and also increasing the dose of progesterone for 4 weeks after initiation of a GLP-1 or after any dose change. You should discuss this further with your GP or prescribing Doctor.

How to order weight loss injections

Our 3-step process makes ordering your weight loss treatment hassle-free and secure.

  • Complete a confidential online consultation and choose a preferred treatment

  • A doctor will review your consultation to make sure it’s right for you

  • If approved, we’ll dispense your treatment and send it via our tracked delivery service

Sometimes we may need to contact you to confirm a few details before making a treatment decision.

Already using weight loss medications?

If you're thinking about switching from Mounjaro to Wegovy, take a look at our switching guide to see if it might be right for you.

Helpful links 

Explore a range of helpful links to aid your weight loss journey. 

References 

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine [Internet]. 2022 Jun 4;387(3):205–16. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2206038. Retrieved May 7, 2026.

  2. Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA [Internet]. 2023 Dec 11;331(1). Available from: https://jamanetwork.com/journals/jama/fullarticle/2812936. Retrieved May 7, 2026.

  3. Wilding JPH, Batterham RL, Calanna S. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine [Internet]. 2021 Feb 10;384(11):989–1002. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2032183. Retrieved May 7, 2026.

  4. James D. STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo [Internet]. Applied Clinical Trials. 2025. Available from: https://www.appliedclinicaltrialsonline.com/view/step-up-trial-semaglutide-superior-weight-loss. Retrieved May 7, 2026.

  5. Ghusn W, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feris F, et al. Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity. JAMA Network Open [Internet]. 2022;5(9):e2231982. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486455/. Retrieved May 7, 2026.

  6. Novo Nordisk Limited. Wegovy® (semaglutide) Summary of Product Characteristics. Available from: https://www.medicines.org.uk/emc [accessed 11 May 2026].

Frequently Asked Questions

View all FAQs

Authored on May 12, 2026

Reviewed on May 12, 2026

Louise Tomlin (Pharmacist)

Louise Tomlin (Pharmacist) - MPharm, MRPharmS

Clinical Governance Pharmacist

GPhC Number: 2056356

Need Help - Weight Loss Injections

Not sure which treatment option is right for you? Fill out your details and an Oxford Online Pharmacy expert will get in touch.

We use the details you provide to respond to your enquiry. Your information is processed in accordance with our Privacy Notice. We will not use your details for marketing without your separate consent.

Related Weight Loss Injections Articles